These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 28158181)
21. Factor V east Texas variant causes bleeding in a three-generation family. Peterson JA; Gupta S; Martinez ND; Hardesty B; Maroney SA; Mast AE J Thromb Haemost; 2022 Mar; 20(3):565-573. PubMed ID: 34847292 [TBL] [Abstract][Full Text] [Related]
22. Investigation of patients with unclassified bleeding disorder and abnormal thrombin generation for physiological coagulation inhibitors reveals multiple abnormalities and a subset of patients with increased tissue factor pathway inhibitor activity. MacDonald S; White D; Langdown J; Downes K; Thomas W Int J Lab Hematol; 2020 Jun; 42(3):246-255. PubMed ID: 32003946 [TBL] [Abstract][Full Text] [Related]
23. Heparin-releasable and platelet pools of tissue factor pathway inhibitor in rabbits. Warn-Cramer BJ; Maki SL; Rapaport SI Thromb Haemost; 1993 Mar; 69(3):221-6. PubMed ID: 8470044 [TBL] [Abstract][Full Text] [Related]
24. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor. Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842 [TBL] [Abstract][Full Text] [Related]
25. Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S. Ellery PER; Hilden I; Sejling K; Loftager M; Martinez ND; Maroney SA; Mast AE Res Pract Thromb Haemost; 2018 Jan; 2(1):93-104. PubMed ID: 29354797 [TBL] [Abstract][Full Text] [Related]
34. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential. Yamamoto J; Inoue N; Otsui K; Ishii H; Gorog DA Thromb Res; 2014 May; 133(5):919-26. PubMed ID: 24613697 [TBL] [Abstract][Full Text] [Related]
35. Decreased tissue factor pathway inhibitor (TFPI)-dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels. Potze W; Arshad F; Adelmeijer J; Blokzijl H; van den Berg AP; Meijers JC; Porte RJ; Lisman T Br J Haematol; 2013 Sep; 162(6):819-26. PubMed ID: 23841464 [TBL] [Abstract][Full Text] [Related]
36. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease. Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809 [TBL] [Abstract][Full Text] [Related]
38. Comparative effects of enoxaparin and unfractionated heparin in healthy volunteers on prothrombin consumption in whole blood during coagulation, and release of tissue factor pathway inhibitor. Bara L; Bloch MF; Zitoun D; Samama M; Collignon F; Frydman A; Uzan A; Bouthier J Thromb Res; 1993 Mar; 69(5):443-52. PubMed ID: 8388583 [TBL] [Abstract][Full Text] [Related]
39. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study. Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291 [TBL] [Abstract][Full Text] [Related]
40. The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI. Raps M; Helmerhorst FM; Fleischer K; Dahm AE; Rosendaal FR; Rosing J; Reitsma P; Sandset PM; van Vliet HA Thromb Haemost; 2013 Apr; 109(4):606-13. PubMed ID: 23407778 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]